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Abstract
Zinc finger nucleases (ZFNs) enable precise genome modification in a variety of organisms and cell types. Commercial ZFNs
were reported to enhance gene targeting directly in mouse zygotes, whereas similar approaches using publicly available
resources have not yet been described. Here we report precise targeted mutagenesis of the mouse genome using
Oligomerized Pool Engineering (OPEN) ZFNs. OPEN ZFN can be constructed using publicly available resources and therefore
provide an attractive alternative for academic researchers. Two ZFN pairs specific to the mouse genomic locus
gt(ROSA26)Sor were generated by OPEN selections and used for gene disruption and homology-mediated gene
replacement in single cell mouse embryos. One specific ZFN pair facilitated non-homologous end joining (NHEJ)-mediated
gene disruption when expressed in mouse zygotes. We also observed a single homologous recombination (HR)-driven gene
replacement event when this ZFN pair was co-injected with a targeting vector. Our experiments demonstrate the feasibility
of achieving both gene ablation through NHEJ and gene replacement by HR by using the OPEN ZFN technology directly in
mouse zygotes.
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Introduction
Mouse lines carrying genes that have been disrupted (knocked-
out) or modified (knocked-in) by homologous recombination (HR)
are important tools that are widely used in biomedical research.
Such lines are generated by gene targeting in mouse embryonic
stem (ES) cells and subsequent morula aggregation or blastocyst
injection of positive clones to generate chimeric animals [1,2].
Despite several improvements aimed at shortening the time frame
of this approach [3] and considerable efforts of consortia such as
EUCOMM, KOMP, or NorCOMM to target all mouse genes
[4,5] engineering the mouse genome remains expensive, time-
consuming and is often plagued by technical problems such as
genomic stability of ES cells and subsequent difficulties in
obtaining germline competent chimeras.
Zinc finger nucleases (ZFNs) have been conceived as an
alternative means of selectively altering the eukaryotic genome
[6]. ZFNs are custom endonucleases that generate double-strand
breaks (DSBs) in their target DNA sequence. Each monomer
consists of 3 to 6 DNA-binding zinc finger modules and the
endonuclease domain of FokI [7]. The zinc finger modules specify
a binding site of 9 to 18 bps thus allowing the design of ZFN pairs
specific for ‘‘half-sites’’ with a total potential specificity of up to
36 bp in length. ZFN pairs can be produced by modular assembly
of one-finger [8,9] or two-finger modules [10,11] with predefined
binding characteristics or by selection-based methods such as the
Oligomerized Pool Engineering (OPEN) protocol developed by
the Zinc Finger Consortium (http://www.zincfingers.org) [12,13].
OPEN relies on a bacterial two-hybrid selection system [12] to
identify ZFNs from combinatorial zinc finger libraries, which
exhibit high activities and specificities for their intended target
sites. OPEN ZFNs have been used to efficiently modify
endogenous genes in zebrafish [14], plants [15,16], and human
somatic [12] and pluripotent stem cells [17,18]. Using the
sequences of a large number of OPEN ZFNs, a selection-free
approach known as Context-Dependent Assembly (CoDA) was
also recently described that yielded active ZFNs in zebrafish and
plants with a success rate of approximately 50% [19,20].
DSBs caused by ZFN activity can be repaired by either error-
prone non-homologous end joining (NHEJ), the dominating DNA
repair mechanism in most eukaryotes [21], or by high fidelity HR
[22]. ZFN-induced mutations caused by mutagenic NHEJ have
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of ZFN mRNAs or ZFN expression constructs directly into
embryos [11,14,23] and similar approaches were also used to
manipulate the genomes of rat [24–26] and mouse [27] following
microinjection of zygotes. In a further refinement, HR-mediated
gene targeting was achieved by co-injection of ZFN mRNAs
together with targeting constructs into mouse and rat zygotes
[28,29]. Most of these experiments were carried out with ZFNs
generated by proprietary technology of Sigma-Aldrich/Sangamo
BioSciences Inc.. By contrast, ZFNs generated using the OPEN
platform and other publicly available assembly kits [30,31] can be
constructed directly by the end user.
Here, we tested two OPEN ZFNs designed to target the mouse
gt(ROSA26)Sor (ROSA26) locus. Our findings demonstrate that
OPEN ZFNs can be used to achieve gene ablation through NHEJ
and gene targeting by HR directly in mouse zygotes.
Results
The mouse ROSA26 locus is a ‘‘safe harbour’’ frequently used
for site-specific insertion of transgenes by HR. Previous studies
have demonstrated the feasibility of gene targeting in the ROSA26
locus by use of commercially available ZFNs [28]. In a
complementary approach we wanted to investigate whether
OPEN ZFNs also allow modification of the ROSA26 locus. Due
to constraints in the targeting range of the OPEN system it was,
however, not possible to target a ZFN pair directly to the XbaI site
in the ROSA26 locus that is frequently used to insert transgenes.
Instead, two ZFN pairs were used in our experiments that could
mediate DNA cuts in proximity of this XbaI site. These ZFN pairs,
90/91 and 204/205, target the ROSA26 sequence 75 and 403 bp
upstream of the XbaI site, respectively (Figure 1A, Table S1).
Initially, we injected ZFN pairs as in vitro synthesised mRNA
into the cytoplasm of zygotes. Specific ZFN activity was estimated
by the number of imprecise NHEJ events in the genome of the
resulting offspring. Cytoplasmic microinjection of mRNAs encod-
ing the 90/91 heterodimeric pair did not result in any discernable
ZFN activity either in the form of mutagenic NHEJ or through
HR upon co-injecting the pRosa26.8 donor construct [28]
(Table 1) that induces alterations at the XbaI site 75 bp
downstream of the 90/91 cleavage site. Also cytoplasmic
microinjection of mRNAs encoding the 204/205 homodimeric
ZFN pair at a concentration of 10 ng/ml appeared to be toxic and
did not result in genome modification through NHEJ. In addition,
we observed high toxicity but no NHEJ or HR after co-injections
of the same mRNAs with targeting vector gtR26_EGFP contain-
ing an EGFP expression cassette sized 3.5 kb and equipped with
1.4 and 1.8 kb long homology arms flanking the ZFN recognition
site (data not shown). This toxicity also persisted upon co-injecting
reduced concentrations (2 ng/ml) of 204/205 homodimeric
mRNAs. Thus, none of the experiments performed with the
heterodimeric pair 90/91 and homodimeric pair 204/205 led to
any discernable activity in mouse zygotes.
Failing to observe any activity with ZFN configurations
described above we proceeded by using heterodimeric versions
of the 204/205 ZFN pair. Cytoplasmic injection of mRNAs
encoding heterodimeric 204/205 ZFNs was well tolerated by the
embryos and led to efficient disruption of the ZFN 204/205 target
sequence in a total of 12 founder animals as detected by FspI
digestion and confirmed through sequence analysis (Figure 1B,C).
Founders carrying NHEJ-mediated disruption were consistently
obtained across several injection sessions (Table 1). One of the
injection series yielded a founder in which both alleles of the
ROSA26 locus had been mutated. These alleles, which could be
discriminated by a C/T SNP 33 bp upstream of the ZFN cleavage
site, contained identical 23 bp deletions (Figure 1A,B, Figure S1B).
To investigate the possibility of using the 204/205 ZFN pair to
induce HR at the ZFN cleavage site, we co-injected the ZFN
mRNAs with a linear DNA fragment of the targeting vector
gtR26_EGFP. We identified 16 fluorescent founder animals and
could confirm that one of them carried the gtR26_EGFP cassette
correctly integrated into the ZFN target site as confirmed by
Southern blot analysis (Figure 2B) as well as by junction PCR and
sequencing (Figure 2B, S2). The integrated EGFP transgene could
be passed to the next generation and remained active in F1
offspring (Figure 2C,D). In further experiments we co-injected the
full-length super-coiled gtR26_EGFP targeting vector, since
vectors with super-coiled topology served as efficient donors in
previous studies [28,29]. We failed, however, to observe HR in this
particular experiment (Table 1).
To test whether integration at the ZFN 204/205 cleavage site
would allow transgene expression under the same transcriptional
control as has been reported before for ROSA26 insertion
transgenes, we co-injected the linear targeting construct
gtR26_tdT carrying a 2.5 kb splice-acceptor tdTomato cassette.
Despite identifying 12 pups that expressed tdTomato and several
others carrying independent NHEJ events, we could not identify
any animals with homologous integration of the gtR26_tdT vector
as determined by Southern blot and junction PCR even though
NHEJ events were present (table 1, data not shown). This result
shows that despite ZFN activity, the gtR26_tdT expression cassette
did not integrate into the ROSA26 locus. This observation was
surprising because the gtR26_tdT vector included identical
homology arms and a smaller insert compared to gtR26_EGFP.
Therefore, we conclude that the 12 tdTomato expressing mice are
most likely the result of random transgene integration and a
partially active ROSA26 promoter that was included in the left
homology arm of the gtR26_tdT construct.
Discussion
Nuclease-assisted gene targeting in zygotes offers a more
expeditious alternative when compared to standard gene targeting
in mouse ES cells. This becomes particularly important for
frequently targeted loci such as ROSA26. An additional advantage
comes with the species and strain-independent cleavage mecha-
nism of ZFNs, which allows generation of germline-competent
founders in all organisms accessible to embryo manipulation [32].
We explored the potential of OPEN ZFNs as an alternative for
targeted transgenesis in mouse embryos and conclude that OPEN
ZFN mRNAs can be used to engineer the mouse genome by direct
zygote injection.
Injection statistics compiled in Table 1 clearly show that in the
case of zygotes expressing the ROSA26 ZFN 204/205 heterodimer
pair NHEJ repair occurs more frequently than HR as described in
earlier studies [28,29]. NHEJ events observed in 4 to 9% of
offspring with this single pair are well within the range of NHEJ
frequencies observed in other studies using ZFNs from OPEN
selection or the CoDA pool in human cells, zebrafish embryos or
plants [12,15,19]. However, in rodent zygotes NHEJ modification
rates above 20% were reported after microinjection of ZFNs
obtained through the Sigma-Aldrich CompoZr service [27–29].
Mosaicism and the presence of two or more modified alleles in a
single animal were frequently observed in these studies. We
identified one founder, ZGFP112, carrying an identical deletion in
both ROSA26 alleles. This genotype could be the result of a
primary NHEJ deletion in one allele which served as a
homologous donor in the subsequent repair of the second DSB
OPEN ZFNs for Gene Targeting in the Mouse Embryo
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proximity to a DSB could have triggered a preferential mode of
end-joining leading to identical outcomes of individual repair
events [27]. Whether the lower ZFN activity rates in our study as
compared to previous studies are the result of locus-dependent
effects, differences in ZFN binding activity, variations in injection
procedures, or lack of codon optimization in our ZFN expression
vectors for expression in mammalian cells will only be revealed by
further comparative studies. Also, a recent study showed that, at
least in cultured cells, the cleavage activity of ROSA26-specific
ZFNs generated by modular assembly [33] increased significantly
upon incorporation of additional ZF modules. However, we note
that this strategy does not always increase activity and care must
be taken with the choice of linkers used to add more fingers
because these more extended ZFNs can potentially bind to a
greater range of off-target sites using subsets of fingers [10].
Meyer and colleagues reported successful vector integration into
ROSA26 in 1.7% to 4.5% of pups born. In our study, HR-
mediated modification of the ROSA26 was observed in a single
germline-competent founder out of 51 mice born after co-injecting
585 zygotes with ZFN 204/205 mRNA and the linear
gtR26_EGFP donor construct. Surprisingly, no targeted integra-
tion was detected when supercoiled gtR26_EGFP, the preferred
donor topology used in earlier studies [28,29], or linear
gtR26_tdT, a targeting vector with identical homology arms,
were co-injected with ZFNs 204/205. Thus, a total of 1500
zygotes were injected with ZFNs 204/205 together with donor
constructs to yield a single targeted founder. While we cannot
formally exclude that the observed targeted integration event
results from the resolution of a spontaneously occurring DSB and
is unrelated to ZFN activity, this scenario seems rather unlikely in
light of previously published data. To date, only one study has ever
Figure 1. Non-homologous end joining repair of ZFN-generated double-strand breaks within the ROSA26 locus. (A) Schematic of ZFN
90/91 and 204/205 target sites within ROSA26 intron 1. ZFN pairs 90/91 and 204/205 target sites 75 bp and 403 bp upstream of the XbaI site (white
arrows), which is routinely used in ROSA26 targeting, respectively. ZFNs 204/205 target a partial FspI recognition sequence. RF and RR, ROSA26
forward and reverse primers used for NHEJ analysis generating a 474 bp fragment (black arrows). (B) Screening for NHEJ repair at the ZFN204/205
cleavage site. Genomic DNA extracted from fetuses or pups developing from ZFN-injected zygotes was amplified with primers RF and RR and
subjected to FspI restriction digest. Most error-prone NHEJ repair events eliminate the FspI recognition sequence (underlined in C) resulting in an
indigestible band at 474 bp. In the majority of founders such as Z20 both modified and wt alleles were detected, however only mutated alleles were
present in founder ZGFP112. (C) Cloning and sequencing of undigested PCR products reveals mutations around the ZFN204/205 cleavage site.
Founder ZGFP112 carried an identical D23 deletion in both ROSA26 alleles. ZFN 204/205 recognition sites highlighted in bold and the spacer region in
grey color.
doi:10.1371/journal.pone.0041796.g001
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construct into the genome of microinjected zygotes and more
than 10,000 zygotes were injected to obtain a single targeting
event in that report [34].
The issue of ZFN toxicity has often been raised as an indicator
for off-target ZFN activity and thus a potential limitation of the
technology. Although the mice generated in this study were not
tested for off-target cleavage events, we have not observed a
marked increase in embryo lethality upon injection of any
heterodimeric ZFNs as compared to conventional pronuclear
injections routinely performed in our laboratory. This is in stark
contrast to microinjections of homodimeric ZFNs, which caused
significant embryo lethality most likely due to more frequent off-
target cleavage events [35].
Thus far, the influence of ZFN activity on gene targeting
efficiency has not been studied comprehensively in microinjected
embryos. However, earlier studies [28,29] suggest a positive
correlation between the number of NHEJ repair events and HR-
mediated targeting events, which both depend on the frequency of
DSBs and ultimately on ZFN activity. The size of the desired
modification is clearly another factor influencing targeting
efficiency with small modifications such as adding or replacing a
small number of nucleotides clearly faring better than experiments
requiring integration of large inserts at the same locus [29].
In our hands only one out of the two ROSA26 OPEN ZFN pairs
showed both NHEJ and HR activities in mouse zygotes. Recently
described novel reporter systems translating nuclease-induced
frameshift events into a switch between two discrete fluorescent
signals [36,37] may be useful to quickly identify active ZFNs in
cultured cells prior to commencing the actual gene targeting
experiments in zygotes. In addition to ZFNs, the recently
described TAL Effector Nucleases (TALENs) show promise as
an alternative method for rapid assembly of site-specific nucleases
[38–42], but have to still prove their potential for use in mouse
oocytes.
Based on the experiments presented here, OPEN ZFNs
represent viable tools for achieving NHEJ-mediated gene knock-
out in mouse zygotes. Since we observed only one event, we
cannot estimate the efficiency of OPEN 204/205 ZFN heterodi-
mers for achieving integration of a targeting vector into the
ROSA26 locus. Only further experiments will reveal how OPEN
ZFNs compare in general with other systems in supporting HR in
mouse zygotes.
Materials and Methods
Animals
Females and males of BDF1 (B57BL/66DBA/2), C57BL/6,
and CD1 mice were purchased from a commercial breeder
(Charles River, Germany). All animals were maintained in
temperature- and light-controlled rooms (12 light/12 dark, light
on from 6:00 a.m.) with food and water ad libidum. All experiments
including laboratory animals were approved by the Cantonal
Veterinary Office of Zurich. The protocol of animal handling and
treatment was in accordance with Swiss Federal and Cantonal
regulations as well as the internal guidelines of the University of
Zurich.
Embryo Collection, Culture and Manipulation
B6D2F1 or C57BL/6 female mice underwent ovulation
induction by intra peritoneal (i.p.) injection of 5 IU pregnant
mare’s serum gonadotrophin (PMSG; Folligon – InterVet,
Switzerland), followed by i.p. injection of 5 IU human chorionic
gonadotropin (hCG; Pregnyl – Essex Chemie, Switzerland) 48 h
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females were mated with the males of the same strain immediately
after the administration of hCG. All zygotes were collected from
oviducts 24 h after the hCG injection and were then freed from
any remaining cumulus cells by a 1–2 min treatment of 0.1%
hyaluronidase (Sigma) dissolved in M2 medium.
Mouse embryos were cultured in M16 (Sigma) medium at 37uC
and 5% CO2. For micromanipulation the embryos were
transferred into M2 medium (Sigma).
Cytoplasmic and pronuclear microinjections
All microinjections were performed using a microinjection
system comprised of an inverted microscope equipped with
Nomarski optics (Nikon, Japan), set of micromanipulators (Nar-
ashige, Japan) and a FemtoJet microinjection unit (Eppendorf,
Germany). ZFN mRNAs were injected into the cytoplasm whereas
the DNA expression constructs and DNA targeting fragments
were injected into the male pronuclei; in experiments where
mRNA and DNA were co-injected the RNA DNA mixture was
first injected into the male pronucleus and subsequently into the
cytoplasm upon the withdrawal of the microinjection capillary.
Specific concentrations of injected mRNAs and DNA constructs
are compiled in Table 1.
Embryo Transfer
Embryos that survived the microinjection were transferred on
the same day into the oviducts of 8–16 weeks old pseudopregnant
CD-1 females (0.5 days post coitus) that have been mated with
sterile TgV males [43] on the day before embryo transfer.
Pregnant females were allowed to deliver and raise their pups or
were sacrificed at 14–16 days post embryo transfer so that the
developing foetuses could be removed for analysis.
Construction of ZFN expression vectors and mRNA
preparation
Zinc finger proteins binding target sites 75 and 403 bp
upstream of the XbaI site within the ROSA26 intron 1 were
selected using the previously described OPEN method [12].
Selected zinc fingers (Text S1) were cloned as XbaI-BamHI
fragment into either the expression vectors pST1374 or
pMLM290/pMLM292 that express homo- or heterodimeric
ZFNs, respectively [35]. In both ZFN expression vectors, the
CMV promoter was replaced by a CMV early enhancer element/
chicken beta-actin promoter (CAG) promoter [44].
In vitro mRNA transcription, capping and polyadenylation, was
performed using the mMESSAGE mMACHINE T7 Ultra Kit.
Prior to injection the mRNAs were purified using the NucAway
Figure 2. ZFN 204/205 promote ROSA26 targeting by homologous recombination in mouse zygotes. (A) HR targeting strategy for the
insertion of the targeting vector gtR26_EGFP carrying EGFP driven by a CAG promoter into the ROSA26 locus. (B) Southern blot analyses of EcoRI
digested genomic DNA from a GFP-fluorescent animal showing site-specific integration into the ROSA26 locus. Both 59 and 39 probes detect only one
expected fragment in the DNA of wild-type (wt) animal. Additional fragments detected in the DNA of targeted animal (ti) are consistent with the
integration of the CAG-EGFP cassette into one of the ROSA26 alleles. (C) Germline transmission of the ROSA26-CAG-EGFP allele was confirmed by
junction PCR in two F1 mice, one of which is depicted in (D). Primers RF, GF, and RR2 generate a 2.5 kb fragment from ROSA26 wt alleles, while an
additional 3.2 kb fragment is amplified from a gtR26_EGFP targeted allele.
doi:10.1371/journal.pone.0041796.g002
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ing gel electrophoresis and concentration was quantified using
spectrophotometry.
Construction of targeting vectors
Targeting vector GTR26 includes a 1.4 kb 59 ROSA26
homology arm and a 1.8 kb 39 ROSA26 homology arm flanking
a central SwaI restriction site. An expression cassette consisting of a
1.6 kb CAG promoter/enhancer followed by the 720 bp EGFP
coding region and the 531 bp rabbit beta-globin polyadenylation
site (3.5 kb in total, including 59 and 39 flanking sequences) was
inserted by blunt cloning into the SwaI site to generate targeting
vector GTR26-EGFP. To generate targeting vector GTR26-tdT a
cassette including the 104 bp Ad2 splice-acceptor followed by a
590 bp triple-STOP-pCMV-IRES fragment, the 1.4 kb tdTomato
coding region and the 256 bp TK polyadenylation signal (2.5 kb
in total, including 59 and 39 flanking sequences) was PCR-
amplified from pXLBluescriptII PTS tdTomato (gift of J. Ruiz and
K. Rector) using primers AGG GCG CAG TAG TCC AGG
GTT TCC and GGC TAT GGC AGG GCT TGC CGC C with
Pfu polymerase and cloned into the SwaI site of the GTR26
targeting vector. To generate a linear fragment all GTR26
2based
targeting vectors were PacI digestion prior to microinjection.
NHEJ and Targeted integration detection assays
Genomic DNA was extracted from mouse biopsies or fetal tissue
using a buffer containing 10 mM Tris-HCl pH 9, 50 mM KCl,
0.45% Nonident p40, 0.45% Tween 20 and Proteinase K.
Extracts were subjected to Phenol/Chloroform/Isoamyl alcohol
purification, precipitated with Isopropanol, and dissolved in EB
buffer (Qiagen).
For detecting NHEJ repair at the ROSA26 locus, primers RF
(GCC GCC CAC CCT CCC CTT CCT C) and RR (CGC CTA
CT CCA CTG CAG CTC CC) were used to amplify a 474 bp
fragment surrounding the ZFN204/205 target site. 25 ml of each
PCR product were digested with FspI and subsequently resolved
on a 2% agarose gel. Samples including undigested PCR
fragments were cloned into pGEM-T easy (Promega) for Sanger
sequencing.
Targeted integration of donor vectors was assessed by junction
PCR and Southern blotting. In case of ZFN204/205 –mediated
ROSA26 targeting primers GF (GCC GGG ATC ACT CTC
GGC ATG) and RR2 (CAC CAC TGG CTG GCT AAA CTC
TGG) amplified the 39 junction that is specific for the integration
of GTR26-204/205-CAG-EGFP into the mouse ROSA26 locus.
For Southern Blot analysis 10 mg of genomic DNA were digested
overnight at 37uC with EcoRI, resolved on a 0.7% agarose gel, and
transferred to nylon membranes. Membranes were heat-fixated at
65uC for 1 h and incubated with prehybdrization solution as
described [45] over night at 65uC. The Rosa 26 59 probe, a
695 bp EcoRI/PacI fragment, was generated from the ‘‘Orkin’’
plasmid. The ROSA26 39 probe, a 615 bp, EcoRI fragment, was
generated from plasmid pCRII-Rosa 39. Hybridization probes
were heat denatured, labeled with P
32 marked dCTP (Perkin
Elmer) using the Ladderman Labelling Kit (Takara). The labeled
probe was purified with illustra MicroSpin S-200 HRcolumns (GE
Healthcare) and heat-denatured probe in hybridization buffer was
added to the membranes for overnight rotation at 65uC.
Membranes were washed three times (5 min) using 26 SSC.
The membranes were exposed at room temperature for 1–3 days
and imaged using a Storm 840 phospho-imager (Molecular
Dynamics). Digital images of Southern Blots were processed with
ImageJ.
Supporting Information
Figure S1 Sequencing of ZFN204/205 cleavage site
within ROSA26 locus. (A) Sequencing traces for NHEJ-
modified ROSA26 alleles. One representative trace per founder is
shown. (B) NHEJ-modified alleles in founder ZGFP112. A deletion
of 23 bp around the ZFN204/205 cleavage site could be identified
in both ROSA26 alleles in founder ZGFP112. The presence of a
C/T SNP (red arrow) 33 bp upstream of the ZFN cleavage site
(underlined in red) in this founder enabled the identification of
individual ROSA26 alleles. Possible regions of microhomology,
which can attract NHEJ repair and increase the likelihood of
certain NHEJ repair outcomes are underlined in black.
(TIF)
Figure S2 Sequencing of junction PCR product ampli-
fied from a founder carrying a targeted ROSA26 allele.
The upper panel shows the parts being sequenced with (1)
covering parts of the EGFP open reading frame and the
polyadenylation signal and (2) covering the junction of ROSA26
genomic DNA and the 39 homology arm of integrated targeting
construct GTR26_EGFP.
(TIF)
Table S1 Sequences of ZFN target sites. Capital letters
denote Zinc finger module binding sequences, bold letters
highlight binding to the parallel or antiparallel strand, respectively.
(PDF)
Text S1 Sequences of OPEN Zinc Finger modules used
in this study.
(PDF)
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